ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
uniQure NV

uniQure NV (QURE)

13,61
-0,75
( -5,22% )
Aktualisiert: 18:50:14
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
13,61
Gebot
13,56
Fragen
13,62
Volumen
266.581
13,58 Tagesbereich 14,5728
3,73 52-Wochen-Bereich 19,18
Marktkapitalisierung
Handelsende
14,36
Handelsbeginn
14,36
Letzte Trade
140
@
13.61
Letzter Handelszeitpunkt
18:50:13
Finanzvolumen
US$ 3.709.200
VWAP
13,914
Durchschnittliches Volumen (3 Mio.)
1.023.251
Ausgegebene Aktien
54.076.880
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,08
Gewinn pro Aktie (EPS)
-4,43
Erlöse
35,05M
Nettogewinn
-239,56M

Über uniQure NV

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipel... uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Amsterdam, North Holland, Nld
Gegründet
-
uniQure NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QURE. The last closing price for uniQure NV was US$14,36. Over the last year, uniQure NV shares have traded in a share price range of US$ 3,73 to US$ 19,18.

uniQure NV currently has 54.076.880 shares in issue. The market capitalisation of uniQure NV is US$776,54 million. uniQure NV has a price to earnings ratio (PE ratio) of -3.08.

Option-Flow uniQure NV (QURE)

Gesamtfluss

Bullisch

Nettoprämie

78k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

QURE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.574.3711656441713.0414.9713.04124869814.02996559CS
42.3921.301247771811.2214.9710.04107339112.97345584CS
12-4.26-23.838836038117.8719.1810.04102325114.10713719CS
268.75180.0411522634.8619.184.45155053213.03752473CS
528.22152.5046382195.3919.183.73162411910.15625126CS
156-3.3-19.515079834416.9128.2553.73110535711.72630558CS
260-31.39-69.75555555564571.453.7386092517.39355836CS

QURE - Frequently Asked Questions (FAQ)

What is the current uniQure NV share price?
The current share price of uniQure NV is US$ 13,61
How many uniQure NV shares are in issue?
uniQure NV has 54.076.880 shares in issue
What is the market cap of uniQure NV?
The market capitalisation of uniQure NV is USD 776,54M
What is the 1 year trading range for uniQure NV share price?
uniQure NV has traded in the range of US$ 3,73 to US$ 19,18 during the past year
What is the PE ratio of uniQure NV?
The price to earnings ratio of uniQure NV is -3,08
What is the cash to sales ratio of uniQure NV?
The cash to sales ratio of uniQure NV is 21,03
What is the reporting currency for uniQure NV?
uniQure NV reports financial results in USD
What is the latest annual turnover for uniQure NV?
The latest annual turnover of uniQure NV is USD 35,05M
What is the latest annual profit for uniQure NV?
The latest annual profit of uniQure NV is USD -239,56M
What is the registered address of uniQure NV?
The registered address for uniQure NV is PAASHEUVELWEG 25A, AMSTERDAM, NORTH HOLLAND, 1105 BP
What is the uniQure NV website address?
The website address for uniQure NV is www.uniqure.com
Which industry sector does uniQure NV operate in?
uniQure NV operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,1684
(191,35%)
1,4B
OSRHOSR Holdings Inc
US$ 3,4299
(114,37%)
75,52M
OCEAOcean Biomedical Inc
US$ 0,12
(111,27%)
646,23M
VVPRVivoPower International PLC
US$ 3,98
(76,11%)
132,32M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,084
(66,01%)
252,68M
BACKIMAC Holdings Inc
US$ 0,0712
(-64,40%)
1,14M
ACRVAcrivon Therapeutics Inc
US$ 3,26
(-39,52%)
943,9k
BHILBenson Hill Inc
US$ 0,275746
(-34,87%)
826,6k
TNONTenon Medical Inc
US$ 2,5097
(-33,07%)
16,58M
HUMAHumacyte Inc
US$ 1,98
(-31,13%)
19,64M
PTPIPetros Pharmaceuticals Inc
US$ 0,1684
(191,35%)
1,4B
OCEAOcean Biomedical Inc
US$ 0,12
(111,27%)
646,23M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,084
(66,01%)
252,68M
NVDANVIDIA Corporation
US$ 113,1475
(-6,25%)
198,24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,618
(-10,40%)
170,76M

QURE Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen